Clinical trial
Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced…
NCT00051558 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00051558 |
|---|---|
| Title | Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis |
| Official title | Comparison of the Effects of Teriparatide With Those of Alendronate Sodium on Lumbar Spine Bone Mineral Density in Glucocorticoid-Induced Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Teriparatide, Alendronate Sodium, Placebo |
| Enrollment | 428 |
| Start date | Nov 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jan 1, 2008 |
| First posted | Jan 14, 2003 |
| Last update posted | Mar 12, 2009 |
| Countries | Austria, Belgium, Denmark, Norway, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: